Compare Cart
  • Japanese
  • Korean
Cover Image
Market Research Report
Product code 
1062945

Erythropoietin (EPO) Global Market Report 2022
Published: Pre-Order | The Business Research Company | 400 Pages | Delivery time: 2-10 business days

Price

Back to Top
Erythropoietin (EPO) Global Market Report 2022
Published: Pre-Order
The Business Research Company
Content info: 400 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents

“Erythropoietin (EPO) Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global erythropoietin (epo) market.

This report focuses on erythropoietin (epo) market which is experiencing strong growth. The report gives a guide to the erythropoietin (epo) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the erythropoietin (epo)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Erythropoietin (EPO) market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider erythropoietin (epo) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The erythropoietin (epo) market section of the report gives context. It compares the erythropoietin (epo) market with other segments of the erythropoietin (epo) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, erythropoietin (epo) indicators comparison.

Scope

Markets Covered:

1) By Product: Epoetin-alfa; Epoetin-beta; Darbepoetin-alfa; Others

2) By Application: Cancer; Hematology; Renal diseases; Neurology; Others

3) By Drug Class: Biologis; Biosimilar

Companies Mentioned:Amgen Inc.; Johnson & Johnson; Roche Group; Pfizer Inc.; Novartis

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: h1167

Table of Contents

1. Executive Summary

2. Erythropoietin (EPO) Market Characteristics

3. Erythropoietin (EPO) Market Trends And Strategies

4. Impact Of COVID-19 On Erythropoietin (EPO)

5. Erythropoietin (EPO) Market Size And Growth

  • 5.1. Global Erythropoietin (EPO) Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Erythropoietin (EPO) Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Erythropoietin (EPO) Market Segmentation

  • 6.1. Global Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others
  • 6.2. Global Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Cancer
  • Hematology
  • Renal diseases
  • Neurology
  • Others
  • 6.3. Global Erythropoietin (EPO) Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Biologis
  • Biosimilar

7. Erythropoietin (EPO) Market Regional And Country Analysis

  • 7.1. Global Erythropoietin (EPO) Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Erythropoietin (EPO) Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Erythropoietin (EPO) Market

  • 8.1. Asia-Pacific Erythropoietin (EPO) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Erythropoietin (EPO) Market

  • 9.1. China Erythropoietin (EPO) Market Overview
  • 9.2. China Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Erythropoietin (EPO) Market

  • 10.1. India Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Erythropoietin (EPO) Market

  • 11.1. Japan Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Erythropoietin (EPO) Market

  • 12.1. Australia Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Erythropoietin (EPO) Market

  • 13.1. Indonesia Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Erythropoietin (EPO) Market

  • 14.1. South Korea Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Erythropoietin (EPO) Market

  • 15.1. Western Europe Erythropoietin (EPO) Market Overview
  • 15.2. Western Europe Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Erythropoietin (EPO) Market

  • 16.1. UK Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Erythropoietin (EPO) Market

  • 17.1. Germany Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Erythropoietin (EPO) Market

  • 18.4. France Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.5. France Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Erythropoietin (EPO) Market

  • 19.1. Eastern Europe Erythropoietin (EPO) Market Overview
  • 19.2. Eastern Europe Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Erythropoietin (EPO) Market

  • 20.1. Russia Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Erythropoietin (EPO) Market

  • 21.1. North America Erythropoietin (EPO) Market Overview
  • 21.2. North America Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Erythropoietin (EPO) Market

  • 22.1. USA Erythropoietin (EPO) Market Overview
  • 22.2. USA Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Erythropoietin (EPO) Market

  • 23.1. South America Erythropoietin (EPO) Market Overview
  • 23.2. South America Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Erythropoietin (EPO) Market

  • 24.1. Brazil Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Erythropoietin (EPO) Market

  • 25.1. Middle East Erythropoietin (EPO) Market Overview
  • 25.2. Middle East Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Erythropoietin (EPO) Market

  • 26.1. Africa Erythropoietin (EPO) Market Overview
  • 26.2. Africa Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Erythropoietin (EPO) Market Competitive Landscape And Company Profiles

  • 27.1. Erythropoietin (EPO) Market Competitive Landscape
  • 27.2. Erythropoietin (EPO) Market Company Profiles
    • 27.2.1. Amgen Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Johnson & Johnson
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Roche Group
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Pfizer Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Novartis
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Erythropoietin (EPO) Pipeline Analysis

29. Key Mergers And Acquisitions In The Erythropoietin (EPO) Market

30. Erythropoietin (EPO) Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer